PMID- 33486266 OWN - NLM STAT- MEDLINE DCOM- 20210426 LR - 20220223 IS - 1618-095X (Electronic) IS - 0944-7113 (Linking) VI - 82 DP - 2021 Feb TI - Herbal formula MaZiRenWan (Hemp Seed Pill) for constipation: A systematic review with meta-analysis. PG - 153459 LID - S0944-7113(21)00001-5 [pii] LID - 10.1016/j.phymed.2021.153459 [doi] AB - BACKGROUND: There is growing interest in using herbal supplements to treat constipation; however, little evidence exists for their use. PURPOSE: This study evaluates the efficacy and safety of herbal formula MaZiRenWan (Hemp Seed Pill, HSP) in patients with functional or non-functional constipation. STUDY DESIGN: Systematic review and meta-analysis METHODS: PubMed, CENTRAL, Embase, CNKI, and Wanfang were searched through April 20, 2020 for randomized trials of HSP versus placebo or medications for all types of constipation. The primary outcomes were complete response rate, complete spontaneous bowel movement (CSBM), patient-reported satisfactory treatment rate (prSTR), and adverse events (AEs). Clinical data were analyzed using a random-effects model, and the quality of evidence was evaluated with the GRADE system. RESULTS: This review includes 1681 constipation patients from 17 moderate-to-high risk of bias trials that were conducted in east Asia. Two high-quality trials showed that HSP compared with placebo significantly increased weekly CSBM (mean difference, 0.95; 95% CI: 0.56, 1.35) and had a higher complete response rate (risk ratio [RR], 1.43; 95% CI: 1.20, 1.71) in patients with functional constipation. Low-quality evidence showed significant improvement in prSTR in HSP compared with conventional medications (RR, 1.79; 95% CI: 1.42, 2.25). Additionally, HSP use did not increase AEs compared with no HSP (p = 0.99). CONCLUSIONS: This study found that HSP was effective among Asian patients with functional constipation. Rigorous trials need to be conducted in clinical populations outside of east Asia and in those with non-functional constipation to increase the generalizability of the evidence. CI - Copyright (c) 2021. Published by Elsevier GmbH. FAU - Yang, Mingxiao AU - Yang M AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. FAU - Feng, Ye AU - Feng Y AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States; Department of Integration of Chinese and Western Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital & Institute, Beijing 100142, China. FAU - Zhang, Yi Lily AU - Zhang YL AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. FAU - Smith, Colleen M AU - Smith CM AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. FAU - Hou, Yen-Nien AU - Hou YN AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. FAU - Wang, Hui AU - Wang H AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange 5, Xicheng District, Beijing, 100053, China. FAU - Deng, Gary AU - Deng G AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. FAU - Mao, Jun J AU - Mao JJ AD - Memorial Sloan Kettering Cancer Center, Bendheim Integrative Medicine Center, 1429 First Avenue, New York, NY, 10021, United States. Electronic address: maoj@mskcc.org. LA - eng PT - Journal Article PT - Systematic Review DEP - 20210105 PL - Germany TA - Phytomedicine JT - Phytomedicine : international journal of phytotherapy and phytopharmacology JID - 9438794 RN - 0 (Drugs, Chinese Herbal) RN - 0 (ma zi ren wan) SB - IM MH - Constipation/*drug therapy MH - Defecation/drug effects MH - Dietary Supplements MH - Drugs, Chinese Herbal/adverse effects/pharmacology/*therapeutic use MH - Humans OTO - NOTNLM OT - Constipation OT - Efficacy OT - MaZiRenWan OT - Safety EDAT- 2021/01/25 06:00 MHDA- 2021/04/27 06:00 CRDT- 2021/01/24 20:39 PHST- 2020/09/22 00:00 [received] PHST- 2020/12/17 00:00 [revised] PHST- 2021/01/01 00:00 [accepted] PHST- 2021/01/25 06:00 [pubmed] PHST- 2021/04/27 06:00 [medline] PHST- 2021/01/24 20:39 [entrez] AID - S0944-7113(21)00001-5 [pii] AID - 10.1016/j.phymed.2021.153459 [doi] PST - ppublish SO - Phytomedicine. 2021 Feb;82:153459. doi: 10.1016/j.phymed.2021.153459. Epub 2021 Jan 5.